Skip to main content
Start of content

HEAL Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

MINUTES OF PROCEEDINGS

Meeting No. 18

Monday, February 3, 2003

The Standing Committee on Health met in a video recorded session at 3:42 p.m. this day, in Room 371, West Block, the Chair, Bonnie Brown, presiding.

Members of the Committee present: Carolyn Bennett, Bonnie Brown, Brenda Chamberlain, Réal Ménard, Rob Merrifield, Carol Skelton, Yolande Thibeault, Greg Thompson, Judy Wasylycia-Leis.

Acting Member present: Larry Spencer for James Lunney

In attendance: From the Library of Parliament: Nancy Miller Chenier and Sonya Norris, Research Officers.

Witnesses: From the Society for Diabetic Rights: Colleen Fuller, President; Brenda Johnson, Vice-President. From the University of Ottawa: Jan T. Braaten, Endocrinologist, Associate Professor, Department of Medicine. From the Department of Health: Julia Hill, Acting Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch; Harold Rode, Acting Manager, Vaccines Division, Health Products and Food Branch; Ian MacKay, Unit Head, Special Access Unit, Clinical Trials and Special Access Programme, Senior Medical Advisor Bureau, Therapeutic Products Directorate, Health Products and Food Branch; Supriya Sharma, Director, Marketed Biologicals and Biotechnology Products Division, Marketed Health Products Directorate, Health Products and Food Branch; Maureen Thompson, Manager, Diabetes Program, First Nations and Inuit Health Branch; Georges Nadon, Pharmaceutical Consultant, Non-Insured Health Benefits Program, First Nations and Inuit Health Branch.

Pursuant to Standing Order 108(2), the Committee held a session on issues concerning synthetic insulin.

Colleen Fuller, Jan Braaten and Julia Hill made statements and, with other witnesses, answered questions.

At 5:45 p.m., the Committee adjourned to the call of the Chair.

 

 

José Cadorette

Clerk of the Committee